Journals / Acta Medica / 2022 / Cilt: 53 - Sayı: 3

Effects of the COVID-19 Pandemic on Patients with Schizophrenia Spectrum Disorders

Pages
267–276
Publication Date
2022-11-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results of patients who reported subjectively increased psychiatric symptoms during the pandemic, while the psychotic symptoms did not worsen during the pandemic, patients with higher anxiety or depression scores reported an increase in their symptoms and were more likely to seek help.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the mental health of patients with schizophrenia spectrum disorders with the prolongation of the pandemic.
📊
Key Findings & Data:Materials and Methods: This descriptive cross-sectional study was conducted between August-October 2020.
💡
Conclusion & Impact:According to the results of patients who reported subjectively increased psychiatric symptoms during the pandemic, while the psychotic symptoms did not worsen during the pandemic, patients with higher anxiety or depression scores reported an increase in their symptoms and were more likely to seek help.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the mental health of patients with schizophrenia spectrum disorders with the prolongation of the pandemic. Materials and Methods: This descriptive cross-sectional study was conducted between August-October 2020. Fifty-two patients with schizophrenia spectrum disorders who were hospitalized prior to the onset of the pandemic between March 2019-March 2020 at the inpatient clinic were reassessed during the pandemic. The Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression-Severity (CGI-S) Scale, Hamilton Depression Rating Scale (HAM-D), Hamilton Anxiety Rating Scale (HAM-A) and Fear of COVID-19 Scale were used to evaluate psychopathology during the pandemic. The PANSS and the CGI severity scores at discharge from the inpatient clinic for each patient were obtained from the medical records review for comparison along with sociodemographic variables. Results: A total of 34 patients, 33 with schizophrenia (97.1%) and 1 with schizoaffective disorder (2.9%) were included. There was no significant difference between the pre- and during the pandemic assessments in the PANSS total and the CGI severity scores. The PANSS total, the CGI, HAM-D, HAM-A and the Fear of COVID-19 scale scores, medical comorbidity and utilization of psychiatric health care services were significantly higher in patients who reported subjectively increased psychiatric symptoms during the pandemic. There was no significant difference in the change of PANSS total and CGI scores between the two groups. Fear of COVID-19 Scale and HAM-A scores were correlated positively. Conclusion: During pandemic increase in psychiatric symptoms may be related not only to psychosis but also depression, anxiety. According to the results of patients who reported subjectively increased psychiatric symptoms during the pandemic, while the psychotic symptoms did not worsen during the pandemic, patients with higher anxiety or depression scores reported an increase in their symptoms and were more likely to seek help.

🔖

Cite This Article

EROĞLU, E. Ö., YILDIZ, M. İ., YAĞCIOĞLU, A. E. A., TÜRKOĞLU, Ö., YALÇINKAYA, O. K., ERTUĞRUL, A., KARAHAN, S., YAZICI, M. K. (2022). Effects of the COVID-19 Pandemic on Patients with Schizophrenia Spectrum Disorders. Acta Medica, Cilt: 53 - Sayı: 3, 267–276. https://ajindex.com/articles/655766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368: m1198
  2. Padala SP, Dennis RA, Caceda R. Why COVID-19 Is Especially Difficult for Those With Schizophrenia: Reasons and Solutions. Prim Care Companion CNS Disord 2020; 2
  3. Wang Q, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry 2021;20:124-130
  4. Kozloff N, Mulsant BH, Stergiopoulos V, et al. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disordersi Schizophr Bull 2020;46:752-757
  5. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence Lancet 2020;395:912-920
  6. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 epidemic in China: a web-based cross-sectional survey. Psychiatry Res 2020;288:112954
  7. Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020;17:1729
  8. Tso IF, Park S. Alarming levels of psychiatric symptoms and the role of loneliness during the COVID-19 epidemic: A case study of Hong Kong. Psychiatry Res 2020;293:113423
  9. Zhand N, Joober R. 2021. Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review. BJPsych Open 2021;7:e35
  10. Stefana A, Youngstrom EA, Chen J, et al. The COVID-19 pandemic is a crisis and opportunity for bipolar disorder. Bipolar Disord 2020;22:641-643
  11. Pinkham AE, Ackerman RA, Depp CA, et al. A Longitudinal Investigation of the Effects of the COVID-19 Pandemic on the Mental Health of Individuals with Pre-existing Severe Mental Illnesses. Psychiatry Res 2020;294:113493
  12. Koreki A, Nakane J, Kitada S, et al. Impact of COVID-19 on psychiatric day care services. Asian J Psychiatr 2020;54:102442
  13. Hoşgelen EI, Alptekin K.COVID-19 Salgınının Şizofreni Hastalarındaki Etkisi. Turk J Psychiatry 2021. doi: 10.5080/ u26175
  14. Barbato A. Schizophrenia and public health. WHO 1998
  15. Sole B, Verdolini N, Amoretti S, et al. Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results fro